Eagle Asset Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
NVPX
NVPX
Eagle Asset Management's HCAT Position: Q2 2020 in Review
Eagle Asset Management sold out of Health Catalyst (HCAT) in Q2 2020, closing a stake of 62,866 shares — an estimated $1.64M sold.
Eagle Asset Management first reported a position in HCAT in Q4 2019 and held it in 2 quarters. The position peaked at $2.01M in Q4 2019. 128 funds tracked by Wall St. Rank hold HCAT as of Q2 2020.
- Eagle Asset Management reported no remaining Health Catalyst position as of Q2 2020 after selling out during the quarter.
- Eagle Asset Management sold 62,866 Health Catalyst shares in Q2 2020, an estimated $1.64M.
- Eagle Asset Management first reported a position in Health Catalyst in Q4 2019 and held it in 2 quarters.
- Eagle Asset Management's Health Catalyst position peaked at $2.01M in Q4 2019.
- 128 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2020.
Based on Eagle Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.